NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium ...
NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium ...
Source: pr-inside.com
📰 Updated Analysis News
Updated Analysis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Updated Analysis. Real-time updates on events, politics, business and more.
Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ® MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual Meeting
SEATTLE, Dec. 05, 2023 -- Adaptive Biotechnologies Corporation , a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to...
Source: marketscreener.com
Lilly Announces Details of Pirtobrutinib Presentations in B-Cell Malignancies at 2023 ASH Annual Meeting
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from studies of pirtobrutinib, a non-covalent (reversible) Brutons tyrosine kinase...
Source: prnewswire.com
Bristol Myers Squibb's First Disclosures and New Data at ASH 2023 Highlight Company's Leadership and Progress in Cell Therapy, Targeted Protein Degradation and Novel Approaches in Hematology -November 02, 2023 at 11:35 am EDT
First presentation of results from primary analysis of Phase 2 TRANSCEND FL study evaluating second-line treatment with Breyanzi® in relapsed or refractory follicular lymphoma demonstrate its...
United States San Diego Sikander Ailawadhi Francesco Passamonti Lisocabtagene Maraleucel Guillaume Cartron
Source: marketscreener.com
INVENTIVA: Inventiva and Echosens launch joint initiative to increase NASH awareness and access to screening for at-risk patients
Daix (France), Long Island City (New York, United States) / Paris (France) and Waltham (United States), June 8, 2023 - Inventiva (Euronext Paris and Nasdaq: IVA) (the "Company"), a clinical-stage biopharmaceutical
Source: finanznachrichten.de
Janssen Presents Efficacy and Subgroup Analyses from MAIA Study Showing Long-Term Results of DARZALEX® (daratumumab)-based Regimen in Newly Diagnosed, Transplant-Ineligible Multiple Myeloma
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new analyses from the Phase 3 MAIA study of DARZALEX® (daratumumab)...
United States Goldschmidth Daratumumab Shaji Kumar Mark Wildgust Christie Corbett Global Medical Affairs
Source: prnewswire.com
Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Clinical Utility and Benefit of clonoSEQ MRD Testing in Blood Cancer Patients at 2022 ASH Annual Meeting
05.12.2022 - SEATTLE, Dec. 05, 2022 (GLOBE NEWSWIRE) - Adaptive Biotechnologies Corporation (Nasdaq: ADPT), together with its collaborators, will present data from more than 30 abstracts showcasing the benefit of Adaptive’s next-generation sequencing ...
New York United States Ciltacabtagene Autoleucel Mary Pat Lancelotta Daratumumab Krd Dara Lenalidomide Vi
Source: wallstreet-online.de
Merck to Present Data From Its Hematology Portfolio and Promising Pipeline at the 64th American Soci
Presentations include new data on investigational medicines – favezelimab (MK-4280), zilovertamab vedotin (MK-2140) and nemtabrutinib (MK-1026) – as well as KEYTRUDA® (pembrolizumab) in multiple blood cancersRAHWAY, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Ca...
Source: pharmiweb.com
Merck to Present Data From Its Hematology Portfolio and Promising Pipeline at the 64th American Society of Hematology (ASH) Annual Meeting
01.12.2022 - Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the presentation of findings from clinical trials and real-world studies at the upcoming 64th American Society of Hematology (ASH) Annual Meeting from Dec. ...
United States Statement Of Merck Co Inc Exchange Commission Merck Co Inc Convention Center Selected Merck
Source: wallstreet-online.de
QBS Canada Announces Independent Study Confirming Benefits
Significant Potential for Financial Saving and Better Outcomes with A Subtle Shift in the Procurement Process...
United States Paul Chinowsky Research Institute University Of Colorado Boulder Procurement Of Consulting Services Updated Analysis
Source: globenewswire.com